{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:42:04Z","timestamp":1774050124362,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biopha.2016.02.011","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T08:43:36Z","timestamp":1457945016000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Xiao-Chun","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-qin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.02.011_bib0005","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA. Cancer J Clin."},{"key":"10.1016\/j.biopha.2016.02.011_bib0010","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2016.02.011_bib0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bjc.2014.377","article-title":"Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer","volume":"111","author":"Letellier","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2016.02.011_bib0020","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ejca.2006.07.006","article-title":"JAK\/STAT signaling pathway in colorectal cancer: a new biological target with therapeutic implications","volume":"42","author":"Spano","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2016.02.011_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/jcp.2005.035113","article-title":"STAT3 mRNA and protein expression in colorectal cancer. Effects on STAT3-inducible targets linked to cell survival and proliferation","volume":"60","author":"Lassmann","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0030","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1074\/jbc.M111.295964","article-title":"Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial mesenchymal transition","volume":"287","author":"Xiong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2016.02.011_bib0035","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signaling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","article-title":"STAT proteins: from normal control of cellular events to tumorigenesis","volume":"197","author":"Cal\u00f2","year":"2003","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0045","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1158\/1078-0432.CCR-08-1328","article-title":"Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting","volume":"14","author":"Koppikar","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.02.011_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/157436212802481619","article-title":"Review: the JAK\/STAT protein activation-role in cancer development and targeted therapy","volume":"7","author":"Daria","year":"2012","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.biopha.2016.02.011_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000147748","article-title":"An overview of epithelio-mesenchymal transformation","volume":"154","author":"Hay","year":"1995","journal-title":"Acta Anat."},{"key":"10.1016\/j.biopha.2016.02.011_bib0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopha.2006.07.058","article-title":"JAK\/STAT signaling in cancer","volume":"60","author":"Heinrich","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.02.011_bib0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","article-title":"Epithelial-mesenchymal transitions in development and pathologies","volume":"15","author":"Thiery","year":"2003","journal-title":"Curr. Opin. Cell. Biol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0070","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-07-5680","article-title":"Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition","volume":"68","author":"Arima","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.02.011_bib0075","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1158\/0008-5472.CAN-09-1872","article-title":"Smad signaling is required to maintain epigenetic silencing during breast cancer progression","volume":"70","author":"Papageorgis","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.02.011_bib0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(01)00365-8","article-title":"Epithelial mesenchymal interactions in cancer and development","volume":"105","author":"Arias","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2016.02.011_bib0085","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.molonc.2014.03.014","article-title":"Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells","volume":"8","author":"David","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0095","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.02.011_bib0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.02.011_bib0110","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/43219","article-title":"Structure and function of a new STAT-induced STAT inhibitor","volume":"387","author":"Naka","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.02.011_bib0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1357-2725(98)00067-3","article-title":"SOCS: suppressors of cytokine signalling","volume":"30","author":"Starr","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2016.02.011_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0501-29","article-title":"SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity","volume":"28","author":"Yoshikawa","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2016.02.011_bib0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s100380300008","article-title":"Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK\/STAT inhibitor, in human hepatoblastomas","volume":"48","author":"Nagai","year":"2003","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.biopha.2016.02.011_bib0130","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","article-title":"SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma","volume":"101","author":"Galm","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2016.02.011_bib0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/gcc.10222","article-title":"SOCS-1 methylation in patients with newly diagnosed acute myeloid leukemia","volume":"37","author":"Chen","year":"2003","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.biopha.2016.02.011_bib0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.bjc.6601039","article-title":"Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms","volume":"89","author":"Fukushima","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2016.02.011_bib0145","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1038\/sj.onc.1205537","article-title":"The tumor suppressor activity of SOCS-1","volume":"21","author":"Rottapel","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2016.02.011_bib0150","doi-asserted-by":"crossref","unstructured":"C.H. Peter, H. Serge, W.H. Kevin, M.H. Heike, M. Sike, M.N. Gerhard, et al., JAK\/STATT signaling in cancer 60 (2006) 488.","DOI":"10.1016\/j.biopha.2006.07.058"},{"key":"10.1016\/j.biopha.2016.02.011_bib0155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ijc.20521","article-title":"Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma","volume":"112","author":"Oshimo","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2016.02.011_bib0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0968-0004(02)02085-6","article-title":"The SOCS box: a tale of destruction and degradation","volume":"27","author":"Kile","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2016.02.011_bib0165","doi-asserted-by":"crossref","first-page":"A46","DOI":"10.1186\/1878-5085-5-S1-A46","article-title":"Mechanism of anti-tumor and anti-invasive function of SOCS isoform in colon cancer models","volume":"5","author":"Kim","year":"2014","journal-title":"EPMA J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215303486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215303486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:59:39Z","timestamp":1760093979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215303486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"alternative-id":["S0753332215303486"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.011","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}